TSX/AMGN (TSX/AMGN)

Toronto Stock Exchange: TSX/AMGN · CAD

CA$33.9

+0.55 (+1.6%)· Recorded snapshot

Market cap	348.5B
Revenue (ttm)	54.1B
Net income (ttm)	12.4B
EPS (ttm)	CA$0.80
P/E (trailing)	42.1x
P/E (forward)	19.0x
Dividend	CA$0.74 (2.18%)
Volume	4,766

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 54.1B
Net income (ttm): 12.4B
EPS (ttm): CA$0.80
P/E (trailing): 42.1x
P/E (forward): 19.0x
Market cap: 348.5B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E19

P25 n/aP50 n/aP75 n/a

Trailing P/E42.1

P25 n/aP50 n/aP75 n/a

ROE91.5

P25 n/aP50 n/aP75 n/a

ROIC19.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TSX/AMGN indicators

Market & fundamental data

Available fields

229

Groups with data

Currency

USD

Showing 229 of 229 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	United States
Country code	CA
Earnings date	2026-11-03
Employees	31,500
Employees change	3,500
Employees growth	12.5%
Enterprise value	CAD 409.3B
Exchange	Toronto Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1980
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	CA03116G1090
Last earnings date	2026-08-04
Last refreshed	2026-10-29
Market cap	CAD 348.5B
Next earnings date	2026-11-03
Price	CAD 33.85
Price currency	CAD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-29
Symbol	tsx/AMGN
Website	https://www.amgen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	25.24x
Average P/E ratio (3Y)	29.44x
Average P/E ratio (5Y)	25.49x
Earnings yield	2.38%
EV/Earnings	32.51x
EV/EBIT	22.6x
EV/EBITDA	16.41x
EV/FCF	27.93x
EV/Sales	7.55x
FCF / EV yield	3.58%
FCF yield	4.21%
Forward P/E	19.05x
Graham number	6.80852
Graham upside	-80.14%
Lynch fair value	CAD 10.87
Lynch upside	-68.29%
P/(FCF - SBC) ratio	24.93x
P/(OCF - SBC) ratio	20.14x
P/B ratio	20.66x
P/E ratio	42.06x
P/FCF ratio	23.73x
P/OCF ratio	19.35x
P/S ratio	6.34x
Price/EBITDA ratio	13.98x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	33.4%
EBITDA margin	45.33%
Effective tax rate	15.01%
FCF margin	27.09%
Gross margin	71.89%
Operating margin	33.4%
Pretax margin	27%
Profit margin	22.95%
Profit per employee	CAD 394,157
Profitable quarters	9
Profitable years	23
Revenue per employee	CAD 1.7M
ROA	8.67%
ROA (5Y)	8.22%
ROCE	18.14%
ROE	91.47%
ROE (5Y)	101.82%
ROIC	19.76%
ROIC (5Y)	20.52%
SBC / revenue	1.29%
Tax / revenue	4.05%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	31.6%
EPS growth (Q)	64.91%
EPS growth (QoQ)	30.84%
EPS growth 10Y	5.12%
EPS growth 3Y	2.72%
EPS growth 5Y	10.3%
EPS growth quarters	6
EPS growth years	1
FCF growth	-4.06%
FCF growth (Q)	82.58%
FCF growth (QoQ)	136.22%
FCF growth 3Y	1.66%
FCF growth 5Y	2.72%
Gross profit growth	13.09%
Gross profit growth (Q)	12.23%
Gross profit growth 3Y	11.58%
Gross profit growth 5Y	7.36%
Net income growth	32.09%
Net income growth (Q)	65.85%
Net income growth (QoQ)	30.57%
Net income growth 3Y	3.09%
Net income growth 5Y	8.76%
Net income growth quarters	6
Net income growth years	1
OCF growth	3.87%
OCF growth (Q)	75.53%
OCF growth (QoQ)	82.82%
OCF growth 10Y	2.7%
OCF growth 3Y	4.93%
OCF growth 5Y	5.48%
Operating income growth	19.55%
Operating income growth (Q)	19.33%
Operating income growth 3Y	8.67%
Operating income growth 5Y	6.56%
Revenue growth	9.1%
Revenue growth (Q)	9.53%
Revenue growth (QoQ)	16.66%
Revenue growth 10Y	5.42%
Revenue growth 3Y	12.74%
Revenue growth 5Y	8.37%
Revenue growth quarters	13
Revenue growth years	6

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -3.3B
Depreciation and amortization	CAD 6.4B
EBIT	CAD 18.1B
EBITDA	CAD 24.5B
EPS	CAD 0.80
Financing cash flow	CAD -5.9B
Free cash flow	CAD 14.4B
Free cash flow minus SBC	CAD 13.8B
Gross profit	CAD 38.9B
Income taxes	CAD 2.2B
Investing cash flow	CAD -3.4B
Net borrowing	CAD 1.8B
Net cash flow	CAD 8.5B
Net income	CAD 12.4B
Operating cash flow minus SBC	CAD 17B
Operating income	CAD 18.1B
Revenue	CAD 54.1B
Stock-based compensation	CAD 698.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.89
Book value per share	CAD 30.70
Debt / EBITDA	3.27
Debt / equity	4.9
Debt / FCF	5.63
Goodwill	CAD 26.1B
Interest coverage	4.14
Long-term assets	CAD 86.9B
Long-term liabilities	CAD 83.5B
Net cash (debt)	CAD -61.5B
Net cash / market cap	-17.94%
Net debt / EBITDA	2.51
Net debt / equity	3.71
Net debt / FCF	4.26
Piotroski F-Score	8
Property, plant and equipment	CAD 12B
Shareholders' equity	CAD 16.6B
Tangible book value	CAD -39B
Tangible book value per share	CAD -72.15
Total assets	CAD 135.8B
Total cash	CAD 19.9B
Total debt	CAD 81.4B
Total liabilities	CAD 119.2B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.42
Current assets	CAD 49B
Current liabilities	CAD 35.7B
Current ratio	1.37
Inventory turnover	1.67
Net working capital	CAD 1.3B
Quick ratio	0.95
Working capital	CAD 13.4B
Working capital turnover	6.88

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.46%
Dividend growth	0%
Dividend growth years	0
Dividend payment date	2026-09-18
Dividend payment years	2
Dividend payout frequency	Quarterly
Dividend per share	CAD 0.74
Dividend yield	2.18%
Ex-dividend date	2026-08-21
Last dividend	CAD 0.19
Payout ratio	60.45%
Shareholder yield	1.69%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 28.23
1D price change	1.65%
1M price change	10.03%
1M total return	10.03%
1W price change	4.78%
1W total return	4.78%
20-day SMA	CAD 31.58
3M price change	16.95%
3M total return	17.63%
50-day SMA	CAD 31.00
52-week high	CAD 34.52
52-week high date	2026-10-29
52-week low	CAD 23.95
52-week low date	2026-05-05
6M price change	34%
6M total return	35.81%
All-time high	CAD 34.52
All-time high date	2026-10-29
All-time low	CAD 23.95
All-time low date	2026-05-05
Average true range (ATR)	CAD 0.60
Average volume	3.9K
Change from 52-week high	-1.94%
Change from 52-week low	41.34%
Change from all-time high	-1.48%
Change from all-time low	42%
Change from open	-1.6%
Day's gap	3.3%
Dollar volume	CAD 161,329
High price	CAD 34.52
Low price	CAD 33.74
Monthly RSI	0
Open price	CAD 34.40
Position in 52-week range	14.1%
Previous close	CAD 33.30
Price vs 150-day SMA	20.48%
Price vs 20-day SMA	7.7%
Price vs 50-day SMA	9.7%
Relative volume	1.23
RSI	69.15
Sharpe ratio	1.57
Sortino ratio	2.48
Volume	4.8K
Weekly RSI	67.28
YTD price change	36.92%
YTD total return	39.71%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	539.2M
Shares change (QoQ)	0%
Shares change (YoY)	0.46%
Shares held by insiders	0.17%
Shares held by institutions	83.73%
Short ratio	4.8 days

Deeper analysis on TSX/AMGN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSX/AMGN report

Is a complete TSX/AMGN research report available?

No complete published report is available for tsx/AMGN (TSX/AMGN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSX/AMGN (TSX/AMGN)

Price

Financial snapshot

Fair-value bridge

Latest news · TSX/AMGN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSX/AMGN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSX/AMGN

Frequently asked questions